Methodist Le Bonheur Healthcare named among Best in Cancer Care by Money magazine 
Hitachi’s Holography Electron Microscope Attains Unprecedented Resolution 
LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser...
Leading Massage Destination Squeeze Expands Footprint in Sarasota, Florida
SARASOTA, FL / ACCESSWIRE / May 23, 2024 / Squeeze, the fast-growing massage service destination, is expanding its personalized massage...
Aytu BioPharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
DENVER, CO / ACCESSWIRE / May 23, 2024 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company...
Sinceri Senior Living Certified as a 2024 Great Place To Work
VANCOUVER, WA / ACCESSWIRE / May 23, 2024 / Great Place To Work Institute and its senior care partner Activated...
Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Product
Oral mucositis, also called "chemo mouth," has emerged as the most significant adverse event in oncology according to a National...
Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults
LAVAL, QC / ACCESSWIRE / May 23, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC),...
OncoveryCare Partners with Tennessee Oncology and Raises $4.5M Seed Round from .406 Ventures
The company is radically redefining the care model for cancer survivorship BOSTON, MA / ACCESSWIRE / May 23, 2024 /...
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
Organizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted...
IRLAB Strengthens its Liquidity by Drawing SEK 25 million on a Previously Secured Loan Facility
GOTHENBURG, SE / ACCESSWIRE / May 23, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 23, 2024 - IRLAB Therapeutics...
Zomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) Therapy
Data supports expanding use of PulseVet Shock Wave therapy to treat equine EIPH and equine asthma ANN ARBOR, MI /...
NanoViricides Bolsters Partnership Efforts – Engages Aagami Inc.
SHELTON, CT / ACCESSWIRE / May 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in...
Vistin Pharma ASA: Minutes from the annual general meeting 2024
Oslo, Norway, 23 May 2024 Vistin Pharma ASA (OSE: VISTN), please find attached the minutes from the annual general meeting...
Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal
Hamilton, Bermuda, May 23, 2024 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA – May 23, 2024 -- Altamira Therapeutics Ltd. (“Altamira” or the...
Brain Cancer Canada Awards an $80,000 research grant to the development of dual function therapies that harness the body’s own immune system to kill brain tumour cells in glioblastomas
TORONTO, May 23, 2024 (GLOBE NEWSWIRE) -- Brain Cancer Canada is excited to announce $80,000 research grant has been awarded...
Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label
- EPA approved an amendment to the label of INTERLINE herbicideto include Camelina -The supplemental label now allows application of...
Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference
MALVERN, Pa., May 23, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing,...
IO Biotech to Present at Jefferies Global Healthcare Conference
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic...
Ashvattha Therapeutics to Present Preclinical Data at the CMSC and SNMMI Annual Meetings
Presentations highlight the therapeutic potential of Ashvattha’s novel CSF1R tyrosine kinase inhibitor (CSF1R dendranib) for multiple sclerosis (MS) based on...
Inozyme Pharma to Present Recently Announced Data from Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE) at Upcoming Medical Conferences
BOSTON, May 23, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical...
MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts
Dallas, TX, May 23, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on...